Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Ani Pharmaceuticals (ANIP) Return on Assets: 2011-2024

Historic Return on Assets for Ani Pharmaceuticals (ANIP) over the last 14 years, with Dec 2024 value amounting to -0.02%.

  • Ani Pharmaceuticals' Return on Assets rose 4.00% to 0.03% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.03%, marking a year-over-year increase of 4.00%. This contributed to the annual value of -0.02% for FY2024, which is 4.00% down from last year.
  • Ani Pharmaceuticals' Return on Assets amounted to -0.02% in FY2024, which was down 175.03% from 0.02% recorded in FY2023.
  • Over the past 5 years, Ani Pharmaceuticals' Return on Assets peaked at 0.02% during FY2023, and registered a low of -0.08% during FY2020.
  • Moreover, its 3-year median value for Return on Assets was -0.02% (2024), whereas its average is -0.02%.
  • Per our database at Business Quant, Ani Pharmaceuticals' Return on Assets decreased by 7bps in 2020 and then grew by 9bps in 2023.
  • Ani Pharmaceuticals' Return on Assets (Yearly) stood at -0.08% in 2020, then grew by 1bps to -0.07% in 2021, then increased by 1bps to -0.06% in 2022, then climbed by 9bps to 0.02% in 2023, then fell by 4bps to -0.02% in 2024.